» Articles » PMID: 35479556

Design, Synthesis and Cytotoxic Evaluation of a Library of Oxadiazole-containing Hybrids

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 Apr 28
PMID 35479556
Authors
Affiliations
Soon will be listed here.
Abstract

The development of hybrid compounds led to the discovery of new pharmacologically active agents for some of the most critical diseases, including cancer. Herein, we describe a new series of oxadiazole-containing structures designed by a molecular hybridization approach. Penicillin derivatives and amino acids were linked to amino acid and aromatic moieties through the formation of a 1,2,4-oxadiazole ring. Alternatively, condensation between amino acid-derived hydrazides and an activated penicillanic acid led to a series of 1,3,4-oxadiazole penicillin-containing hybrids and non-cyclized diacylhydrazides. From the cytotoxicity assays it is highlighted that two 1,2,4-oxadiazoles and one 1,3,4-oxadiazole connecting a penicillin and aliphatic amino acids displayed a high degree of cytotoxic selectivity, ranging between being three and four times more potent against tumor cells than normal cells. The results give a very interesting perspective suggesting that these hybrid compounds can offer a novel antitumor scaffold with promising cytotoxicity profiles.

Citing Articles

Discovery from Hypericum elatoides and synthesis of hyperelanitriles as α-aminopropionitrile-containing polycyclic polyprenylated acylphloroglucinols.

Xie J, Li P, Yan X, Gao J Commun Chem. 2024; 7(1):1.

PMID: 38167859 PMC: 10762030. DOI: 10.1038/s42004-023-01091-1.

References
1.
Galloway W, Isidro-Llobet A, Spring D . Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat Commun. 2010; 1:80. DOI: 10.1038/ncomms1081. View

2.
Weinmann H . Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators. ChemMedChem. 2016; 11(5):450-66. DOI: 10.1002/cmdc.201500566. View

3.
Bondebjerg J, Fuglsang H, Valeur K, Kaznelson D, Hansen J, Pedersen R . Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI). Bioorg Med Chem. 2005; 13(14):4408-24. DOI: 10.1016/j.bmc.2005.04.048. View

4.
Li Z, Chen W, Hale J, Lynch C, Mills S, Hajdu R . Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3. J Med Chem. 2005; 48(20):6169-73. DOI: 10.1021/jm0503244. View

5.
OConnor C, Laraia L, Spring D . Chemical genetics. Chem Soc Rev. 2011; 40(8):4332-45. DOI: 10.1039/c1cs15053g. View